| Literature DB >> 25656667 |
Francis D LaBarbera1, Ivan Nikiforov2, Arvin Parvathenani2, Varsha Pramil2, Subhash Gorrepati2.
Abstract
BACKGROUND: Clostridium difficile infection (CDI) is a growing problem in the community and hospital setting. Its incidence has been on the rise over the past two decades, and it is quickly becoming a major concern for the health care system. High rate of recurrence is one of the major hurdles in the successful treatment of C. difficile infection. There have been few studies that have looked at patterns of recurrence. The studies currently available have shown a number of risk factors associated with C. difficile recurrence (CDR); however, there is little consensus on the impact of most of the identified risk factors.Entities:
Keywords: Random Forest; hospital infection; machine learning algorithm
Year: 2015 PMID: 25656667 PMCID: PMC4318823 DOI: 10.3402/jchimp.v5.26033
Source DB: PubMed Journal: J Community Hosp Intern Med Perspect ISSN: 2000-9666
Explanatory variables used in this study
| Age | Smoking |
| Coronary artery disease | Low-risk antibiotics |
| Chronic kidney disease | High-risk antibiotics |
| Gastrointestinal (GI) malignancy | H2 antagonist |
| Gender | Alcohol use |
| Peptic ulcer disease | No GI surgery |
| Inflammatory bowel disease | One GI surgery |
| Immunosuppression | Two GI surgeries |
| Race | Hypertension |
| Gastro esophageal reflux disease | Proton pump inhibitor (PPI) 20 mg |
| Corticosteroids | PPI 40 mg |
| Chemotherapy | PPI 80 mg |
| Diabetes |
Fig. 1Receiver operating curve with area under curve.
Demographic and risk factor table
| No recurrence | Recurrence |
| |||
|---|---|---|---|---|---|
| Total number of patients | 168 | 30 | |||
| Demographics | |||||
| Age (mean, SD, range) | 68.7 (17.7) | 3–96 | 70.8 (17.0) | 28–93 | 0.5339 |
| Male (number,%) | 62 | 36.69 | 17 | 56.67 | 0.0393 |
| Race | |||||
| Caucasian | 151 | 89.35% | 25 | 83.33% | 0.3544 |
| African American | 9 | 5.33% | 4 | 13.33% | 0.1126 |
| Others | 9 | 5.33% | 1 | 3.33% | 1 |
| Risk factors | |||||
| Smoking | 60 | 35.50% | 8 | 26.67% | 0.3364 |
| ETOH | 43 | 25.44% | 8 | 26.67% | 0.8876 |
| Hypertension | 133 | 78.70% | 22 | 73.33% | 0.5141 |
| CAD | 78 | 46.15% | 12 | 40.00% | 0.5326 |
| CKD | 51 | 30.18% | 11 | 36.67% | 0.4794 |
| Diabetes | 56 | 33.14% | 12 | 40.00% | 0.4651 |
| GERD | 46 | 27.22% | 8 | 26.67% | 0.9500 |
| PUD | 11 | 6.51% | 3 | 10.00% | 0.4479 |
| IBD | 3 | 1.78% | 0 | 0.00% | 1.0000 |
| IBS | 6 | 3.55% | 1 | 3.33% | 1.0000 |
| GI cancer | 5 | 2.96% | 1 | 3.33% | 1.0000 |
| Immunosuppressed | 23 | 13.61% | 4 | 13.33% | 1.0000 |
| Low-risk antibiotics | 55 | 32.54% | 11 | 36.67% | 0.6585 |
| High-risk antibiotics | 104 | 61.54% | 17 | 56.67% | 0.6145 |
| H2 antagonist | 13 | 7.69% | 1 | 3.33% | 0.6988 |
| Corticosteroids | 26 | 15.38% | 9 | 30.00% | 0.0527 |
| Chemotherapy | 14 | 8.28% | 1 | 3.33% | 0.7022 |
| Number of GI surgeries | |||||
| One | 35 | 20.71% | 12 | 40.00% | 0.0219 |
| Two or more | 16 | 9.47% | 3 | 10.00% | 1.0000 |
| None | 118 | 69.82% | 15 | 50.00% | 0.0336 |
| PPI dose | |||||
| 20 mg | 16 | 9.47% | 4 | 13.33% | 0.5126 |
| 40 mg | 117 | 69.23% | 16 | 53.33% | 0.0883 |
| 80 mg | 1 | 0.59% | 3 | 10.00% | 0.0113 |